Jin Rong Jie·2025-04-29 03:28Market Overview - The stock market experienced significant volatility due to President Trump's latest tariff announcements, with investors awaiting potential agreements between the U.S. and trade partners [1] - Major indices rebounded after an initial decline, with the S&P 500 rising over 4%, the Nasdaq Composite increasing nearly 7%, and the Dow Jones Industrial Average gaining over 2% [1] Company Performance - VeriSign's stock rose 8% on Friday, reaching a new intraday high, following a strong first-quarter revenue report and the announcement of a cash dividend of $0.77 per share [4] - Netflix's stock also reached a new intraday high, increasing over 13% for the week, driven by a 13% growth in first-quarter revenue attributed to strong subscription and advertising income [5] Stock Analysis - VeriSign is identified as one of the overbought stocks with an RSI of 70.45, indicating potential short-term pullback risks despite a target price suggesting over 7% downside [2] - Netflix's average target price is approximately $1,116, indicating only about 1% upside potential from the recent closing price [6] - Bristol-Myers Squibb and UnitedHealth Group are noted as oversold stocks, with RSIs of 24.41 and 28.87 respectively, and both companies have underperformed the market [7] - Bristol-Myers Squibb's stock has dropped over 21.5% in April, while UnitedHealth's has decreased by 20.1% year-to-date [10] Future Outlook - Bristol-Myers Squibb has raised its full-year revenue and earnings guidance, while UnitedHealth has lowered its full-year performance outlook due to rising medical costs [9] - Market consensus target prices suggest over 17% upside potential for Bristol-Myers Squibb and over 36% for UnitedHealth [10]